Takahiro Kojima

12PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 01, 2026
Real-World Outcomes and Prognostic Factors of Immune Checkpoint Inhibitor Rechallenge for Metastatic Renal Cell Carcinoma: A Multicenter Study.

|Jun 29, 2026
Editorial Comment on Rapid Systemic Progression After Ureteroscopic Holmium:YAG Laser Ablation for High-Grade Upper Tract Urothelial Carcinoma in a Solitary Kidney: A Case Report.

|May 02, 2026
Optimizing management of small renal masses: a patient-centered approach to minimize overtreatment.

|Dec 01, 2025
A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol.

Takashi Matsumoto, Tokiyoshi Tanegashima, Ario Takeuchi

|Oct 06, 2025
Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study).

Naoki Terada, Keiji Nihei, Rihito Aizawa

|Feb 02, 2025
Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.

Hiroshi Kikuchi, Takahiro Osawa, Yuto Matsushita

Pageof 2

Frequent Collaborators

3 joint publications

Takahiro Kimura

3 joint publications

Yuto Matsushita

3 joint publications

Kazuyuki Numakura

2 joint publications

Masaki Shiota